Published in Leukemia on February 01, 2003
Cell line misidentification: the beginning of the end. Nat Rev Cancer (2010) 2.87
Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clin Cancer Res (2011) 2.31
Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci U S A (2005) 1.78
Sources of error in the retracted scientific literature. FASEB J (2014) 1.60
High-throughput detection and multiplex identification of cell contaminations. Nucleic Acids Res (2009) 1.49
Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2. PLoS One (2009) 1.49
High-throughput SNP-based authentication of human cell lines. Int J Cancer (2012) 1.46
Reproducibility: changing the policies and culture of cell line authentication. Nat Methods (2015) 1.43
A bioinformatics analysis of the cell line nomenclature. Bioinformatics (2008) 1.33
Comparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling data. BMC Genomics (2006) 1.24
Molecular characterization of putative chordoma cell lines. Sarcoma (2010) 1.09
The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF. Cancer Res (2014) 1.08
Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls. Front Oncol (2013) 1.02
A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers. Cancer Res (2011) 0.97
The need for a worldwide consensus for cell line authentication: Experience implementing a mandatory requirement at the International Journal of Cancer. PLoS Biol (2017) 0.96
FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA. Int Immunol (2010) 0.94
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer (2004) 0.94
Molecular and functional characterization of Hv1 proton channel in human granulocytes. PLoS One (2010) 0.92
Identification and verification of rodent cell lines by polymerase chain reaction. Cytotechnology (2007) 0.90
The necessity of identity assessment of animal intestinal cell lines: A case report. Cytotechnology (2011) 0.88
Human biosample authentication using the high-throughput, cost-effective SNPtrace(TM) system. PLoS One (2015) 0.87
Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines. Br J Cancer (2006) 0.86
Prevention and detection of Mycoplasma contamination in cell culture. Cell J (2011) 0.86
Simultaneous localization of MLL, AF4 and ENL genes in interphase nuclei by 3D-FISH: MLL translocation revisited. BMC Cancer (2006) 0.85
The stimulation of PD-L1-specific cytotoxic T lymphocytes can both directly and indirectly enhance antileukemic immunity. Blood Cancer J (2014) 0.84
LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines. Clin Exp Metastasis (2004) 0.80
Induction of apoptosis by cross-linking antibodies bound to human B-lymphoma cells: expression of Annexin V binding sites on the antibody cap. Cancer Biother Radiopharm (2009) 0.79
Processing of Neutrophil α-Defensins Does Not Rely on Serine Proteases In Vivo. PLoS One (2015) 0.77
INF-γ Enhances Nox2 Activity by Upregulating phox Proteins When Applied to Differentiating PLB-985 Cells but Does Not Induce Nox2 Activity by Itself. PLoS One (2015) 0.76
Detection algorithm for the validation of human cell lines. Int J Cancer (2012) 0.75
P39/Tsugane cells are a false cell line contaminated with HL-60 cells and are not suitable for mechanistic studies in myelodysplastic syndromes. Haematologica (2010) 0.75
CRISPR/Cas9-generated p47(phox)-deficient cell line for Chronic Granulomatous Disease gene therapy vector development. Sci Rep (2017) 0.75
Creation of a human T-ALL cell line online database. Leuk Lymphoma (2017) 0.75
[U-HO1. A new cell line derived from a primary refractory classical Hodgkin lymphoma]. Pathologe (2008) 0.75
Functional annotation of a full-length mouse cDNA collection. Nature (2001) 23.61
Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci U S A (2001) 4.84
Identification of the coding sequence for a reverse transcriptase-like enzyme in a transposable genetic element in Drosophila melanogaster. Nature (1985) 4.31
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet (2004) 2.96
Naturally occurring variation in the restriction map of the amy region of Drosophila melanogaster. Genetics (1988) 2.74
Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol (2003) 2.52
Structural genomics projects in Japan. Nat Struct Biol (2000) 2.40
Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer (1999) 2.20
MMDB: Entrez's 3D structure database. Nucleic Acids Res (1999) 2.17
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders. Leukemia (2006) 1.90
Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia (1998) 1.68
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin. Leukemia (2005) 1.67
ECV304 (endothelial) is really T24 (bladder carcinoma): cell line cross- contamination at source. In Vitro Cell Dev Biol Anim (2000) 1.63
Specificity and distribution of alpha antigens of Mycobacterium avium-intracellulare, Mycobacterium scrofulaceum, and related species of mycobacteria. Am Rev Respir Dis (1985) 1.62
Reexamination of diversifying selection of polymorphic allozyme genes by using population cages in Drosophila melanogaster. Proc Natl Acad Sci U S A (1983) 1.49
Differential diagnosis between thymoma and non-thymoma by dynamic MR imaging. Acta Radiol (2002) 1.46
Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia (2000) 1.45
Measurement of tissue oxygen consumption in patients with mitochondrial myopathy by noninvasive tissue oximetry. Neurology (1997) 1.42
Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men. Ann Intern Med (2000) 1.42
Deleted HTLV provirus in peripheral blood cells of a patient with T-cell prolymphocytic leukaemia. Br J Haematol (1998) 1.41
Neutrophil-specific antigens and gene frequencies in Japanese. Transfusion (1989) 1.40
A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia (2000) 1.36
A Di-leucine signal in the ubiquitin moiety. Possible involvement in ubiquitination-mediated endocytosis. J Biol Chem (2000) 1.35
Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma. Leukemia (2000) 1.27
Purification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2. Immunol Lett (1996) 1.26
Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements. Proc Natl Acad Sci U S A (2003) 1.26
Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology (2000) 1.22
HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3. Leukemia (2005) 1.21
In situ identification of polyphosphate- and polyhydroxyalkanoate-accumulating traits for microbial populations in a biological phosphorus removal process. Environ Microbiol (2001) 1.20
Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. Leuk Res (2000) 1.18
Denitrification, a novel type of respiratory metabolism in fungal mitochondrion. J Biol Chem (1996) 1.18
New therapeutic possibility of blocking cytokine-induced neutrophil chemoattractant on transient ischemic brain damage in rats. Brain Res (1997) 1.17
Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization. Blood (1992) 1.16
A novel epidermal cell differentiation inhibitor (EDIN): purification and characterization from Staphylococcus aureus. Biochem Biophys Res Commun (1990) 1.16
Interleukin-18/interferon-gamma-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J Leukoc Biol (1998) 1.16
Denitrification by the fungus Cylindrocarpon tonkinense: anaerobic cell growth and two isozyme forms of cytochrome P-450nor. Appl Environ Microbiol (1995) 1.11
White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men. Diabetologia (2002) 1.09
Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. Blood (1999) 1.08
CD28 molecule as a receptor-like function for accessory signals in cell-mediated augmentation of IL-2 production. Cell Immunol (1990) 1.07
Specificity and distribution of alpha antigens of Mycobacterium kansasii and Mycobacterium marinum. Am Rev Respir Dis (1984) 1.07
Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations. Leukemia (2004) 1.05
Characteristics of Japanese alcoholics with the atypical aldehyde dehydrogenase 2*2. I. A comparison of the genotypes of ALDH2, ADH2, ADH3, and cytochrome P-4502E1 between alcoholics and nonalcoholics. Alcohol Clin Exp Res (1996) 1.05
The 1.8-A X-ray structure of the Escherichia coli PotD protein complexed with spermidine and the mechanism of polyamine binding. Protein Sci (1996) 1.04
Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma. Leukemia (2007) 1.03
Purification and antigenic specificity of alpha protein (Yoneda and Fukui) from Mycobacterium tuberculosis and Mycobacterium intracellulare. Hiroshima J Med Sci (1983) 1.00
Structural genomics projects in Japan. Prog Biophys Mol Biol (2000) 1.00
Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain. Neuroradiology (2001) 1.00
Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma. Clin Cancer Res (2001) 0.99
Sclerosing stromal tumor of the ovary: radiologic findings. Eur Radiol (1999) 0.99
Cyclosporin A protects against ischemia-reperfusion injury in the brain. Brain Res (1992) 0.99
MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines. Leukemia (2007) 0.99
Integrin-linked kinase activity is associated with interleukin-1 alpha-induced progressive behavior of pancreatic cancer and poor patient survival. Oncogene (2006) 0.99
Expression of four CEA family antigens (CEA, NCA, BGP and CGM2) in normal and cancerous gastric epithelial cells: up-regulation of BGP and CGM2 in carcinomas. Int J Cancer (1998) 0.98
Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2. J Biochem (2001) 0.98
Additional translocation (8;21)(q22;q22) in a patient with Philadelphia-positive chronic myelogenous leukaemia in the blastic phase. Br J Haematol (1999) 0.98
Hours of work and the risk of developing impaired fasting glucose or type 2 diabetes mellitus in Japanese male office workers. Occup Environ Med (2001) 0.98
Prediction of protein secondary structure using the 3D-1D compatibility algorithm. Comput Appl Biosci (1997) 0.97
Expression of the ryanodine receptor isoforms in immune cells. J Immunol (2001) 0.97
The coordination of gastrointestinal hormones and the autonomic nerves. Am J Gastroenterol (1978) 0.96
Genetic Analysis of Natural Populations of DROSOPHILA MELANOGASTER in Japan. III. Genetic Variability of Inducing Factors of Amylase and Fitness. Genetics (1984) 0.96
A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease. J Biochem (1993) 0.96
False human hematopoietic cell lines: cross-contaminations and misinterpretations. Leukemia (1999) 0.95
Comparison of protein structures using 3D profile alignment. J Mol Evol (1997) 0.95
Carcinoma in situ of the pancreas associated with localized fibrosis: a clue to early detection of neoplastic lesions arising from pancreatic ducts. Pancreas (1998) 0.94
Transient increase of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in ischemic brain areas after focal ischemia in rats. Stroke (1995) 0.94
Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas. Am J Pathol (1994) 0.94
Is it possible to differentiate between choledochal cyst and congenital biliary atresia (type I cyst) by antenatal ultrasonography? Fetal Diagn Ther (1998) 0.94
U-2932: two clones in one cell line, a tool for the study of clonal evolution. Leukemia (2012) 0.94
Development of pseudoenergy potentials for assessing protein 3-D-1-D compatibility and detecting weak homologies. Protein Eng (1993) 0.93
Predicted structure of the extracellular region of ligand-gated ion-channel receptors shows SH2-like and SH3-like domains forming the ligand-binding site. Protein Sci (1997) 0.93
Screening of drugs for activity against Mycobacterium leprae. Int J Lepr Other Mycobact Dis (1987) 0.92
Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats. Diabetes (2000) 0.92
Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus -negative leukemia cell lines. Leukemia (2007) 0.92
T(3;7)(q27;q32) fuses BCL6 to a non-coding region at FRA7H near miR-29. Leukemia (2007) 0.91
Letter: Decreasing frequency of e antigen with age in serum of symptom-free carriers of hepatitis B antigen. Lancet (1976) 0.91
A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy. J Neurol Neurosurg Psychiatry (1995) 0.91
FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23). Leukemia (2004) 0.91
Three novel molecular forms of biliary glycoprotein deduced from cDNA clones from a human leukocyte library. Biochem Biophys Res Commun (1991) 0.91
Automated search of natively folded protein fragments for high-throughput structure determination in structural genomics. Protein Sci (2000) 0.91
Intrapancreatic duodenal duplication associated with pancreatic pseudocysts. J Pediatr Surg (1992) 0.90
Testicular malignant lymphoma; imaging and diagnosis. Radiat Med (1996) 0.90
Alanyl glutamine-enriched total parenteral nutrition restores intestinal adaptation after either proximal or distal massive resection in rats. JPEN J Parenter Enteral Nutr (1993) 0.90
Interleukin-6 levels in colorectal cancer tissues. World J Surg (1998) 0.90
Molecular cloning of nonspecific cross-reacting antigens in human granulocytes. J Biol Chem (1991) 0.90
Endoscopic mucosal resection and endoscopic submucosal dissection for en bloc resection of superficial pharyngeal carcinomas. Endoscopy (2012) 0.90
ABL-BCR expression in BCR-ABL-positive human leukemia cell lines. Leuk Res (1999) 0.89
Magnetic compression anastomosis for benign obstruction of the common bile duct. Endoscopy (2001) 0.89
Gene expression of ecdysteroid-regulated gene E74 of the honeybee in ovary and brain. Insect Mol Biol (2005) 0.89
Malignant hematopoietic cell lines: in vitro models for the study of anaplastic large-cell lymphoma. Leukemia (2004) 0.89
DNA profiling and cytogenetic analysis of cell line WSU-CLL reveal cross-contamination with cell line REH (pre B-ALL). Leukemia (2002) 0.88
Novel non-TCR chromosome translocations t(3;11)(q25;p13) and t(X;11)(q25;p13) activating LMO2 by juxtaposition with MBNL1 and STAG2. Leukemia (2011) 0.88
Inhibitory effects of anti-oxidants on apoptosis of a human polyclonal T-cell line, MT-2, induced by an asbestos, chrysotile-A. Scand J Immunol (2005) 0.87
Myxolipoma mimicking a cystic tumor. Skeletal Radiol (1996) 0.87
Structurally altered Evi-1 protein generated in the 3q21q26 syndrome. Oncogene (1996) 0.87